GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
Genetic Technologies Ltd - American Depositary Shares (GENE)
US:NASDAQ Investor Relations:
gtgcorporate.com/investor-centre
Company Research
Source: GlobeNewswire
MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the company’s latest milestones along with our clinical adoption of the Company’s groundbreaking geneType Risk Assessment Tests routinely across 12 states in the United States and nationally in Australia. The geneType team has achieved clinical proof of concept in key markets including general practice, oncology, and gynecology with repeat sales in each of these markets. Increasingly clinicians are realising the importance of genetic screening for disease, particularly in at risk patients. The ability to “know” a patient’s risk provides clinicians with an opportunity to offer a greater standard of care and more closely monitor those at risk. Clinicians embracing and offering geneType to patients have tended to be: Early adoptersComfortable
Show less
Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GENE alerts
High impacting Genetic Technologies Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GENE
News
- Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingGlobeNewswire
- Genetic Technologies stock tumbles on direct offering pricing [Seeking Alpha]Seeking Alpha
- Genetic Technologies Announces $2 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Genetic Technologies Announces $2 Million Registered Direct OfferingGlobeNewswire
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes [Yahoo! Finance]Yahoo! Finance
GENE
Sec Filings
- 4/23/24 - Form 6-K
- 4/23/24 - Form 6-K
- 4/23/24 - Form 6-K
- GENE's page on the SEC website